Company: JUNS
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010990
Chunk: 3

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 1
Chunk 3
---
 options for the forgiveness of accrued salaries and accrued bonuses 
     -  
     -  
     50,000  
     -  
     50,000 
  
    Net  loss 
     -  
     -  
     -  
     (634,100) 
     (634,100)
  
    March 31, 2024 
     26,526,405  
    $3,310  
    $18,193,815  
    $(24,216,604) 
    $(6,020,137)
  
    Balance 
     26,526,405  
    $3,310  
    $18,193,815  
    $(24,216,604) 
    $(6,020,137)

The accompanying notes are an integral part of these
condensed consolidated financial statements

7

JUPITER NEUROSCIENCES, INC.

 CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

    March 31, 2025   
    March 31, 2024  
  
    Cash Flows from Operating Activities: 

    Net Loss 
    $(1,528,867) 
    $(634,100)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Loss on change in fair value of derivative liability 
     -  
     37,711 
  
    Amortization of debt discounts 
     -  
     4,986 
  
    Gain on forgiveness of accrued compensation 
     -  
     (40,000)
  
    Amortization of prepaid contracts 
     189,041  
     - 
  
    Stock-based compensation 
     421,454  
     355,317 
  
    Changes in operating assets and liabilities: 

    Prepaid and other current assets 
     (24,106) 
     - 
  
    Operating lease right of use asset 
     (659) 
     (199)
  
    Accounts payable and accrued expenses 
     (113,552) 
     13,205 
  
    Accrued compensation 
     (7,435) 
     178,832 
  
    Increase in accrued interest 
     1,083  
     19,083 
  
    Net cash flows from